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Résumé de thèse 
L'enjeu et le contexte de la recherche : 
Déterminer le taux ou le débit de filtration glomérulaire (en anglais « GFR » ou 
«glomerular filtration rate») est crucial en pédiatrie afin de pouvoir adapter les 
posologies des médicaments prescrits et suivre l'évolution de la fonction rénale chez 
les patients souffrant d'une maladie rénale ou présentant le risque de développer 
une insuffisance rénale. La manière la plus précise pour déterminer le GFR est de le 
mesurer. Cependant les méthodes utilisées pour mesurer le GFR sont coûteuses, 
contraignantes et elles ne sont pas disponibles dans tous les hôpitaux, d'où 
l'importance de développer une formule fiable permettant d'estimer le GFR. 
L'article: 
Plusieurs formules pour estimer le GFR (eGFR) à partir de marqueurs endogènes 
comme la créatinine plasmatique et/ou plus récemment la cystatine C sanguine ont 
été développées chez l'enfant. La formule la plus couramment utilisée en pédiatrie 
est la formule de Schwartz qui a été révisée en 2009 en se référant à une cohorte 
d'enfants avec un GFR mesuré par des clearances à l'iohexol entre 15 et 75 ml/min x 
1, 73 m2 . Dans cet article, nous avons étudié la validité de la nouvelle formule de 
Schwartz dans une population d'enfants présentant un plus large spectre de degré 
d'insuffisance rénale en y incluant des enfants avec un GFR normal ou une 
hyperfiltration glomérulaire. Nous avons comparé 551 clairances à l'inuline (le « gold 
standard » pour mesurer le GFR) de 392 enfants âgés de 3 à 18 ans avec leurs 
eGFRs selon Schwartz dans une étude rétrospective et prospective. La créatinine 
sérique est mesurée en utilisant la méthode de Jaffe compensée. Selon nos 
résultats, la formule de Schwartz est applicable jusqu'à une valeur de taille/créatinine 
sérique de 251 qui correspond à un iGFR de 103ml/min x 1 ,73m2 • Cependant, cette 
formule manque de précision chez les enfants présentant un iGFR au-delà de cette 
valeur, ce qui correspond soit à une insuffisance rénale légère, soit à un GFR normal 
ou encore à une hyperfiltration glomérulaire. En effet, la corrélation entre les iGFRs 
et la variable de la formule de Schwartz (taille/créatinine sérique) n'est pas linéaire 
comme décrite par Schwartz mais plutôt quadratique, raison pour laquelle nous 
avons développé la formule suivante à l'aide d'un modèle de régression 
quadratique : 
O. 68 x (taille( cm)/ créatinine sérique (mg/dl)) - O. 0008 x (taille (cm)/ créatinine sérique 
(mg/dl ))2 + 0.48 x âge (années) - (25,68 pour les filles ou 21,53 pour les garçons). 
Nous avons validé cette nouvelle formule quadratique par la méthode de validation 
interne croisée et par une nouvelle étude prospective incluant 127 iGFRs de 127 
enfants (validation externe). En conclusion, la nouvelle formule quadratique est 
applicable à toutes les classes du GFR chez l'enfant et pourrait remplacer la formule 
de Schwartz. 
Les conclusions et les perspectives : 
Cette étude contribue à affiner le champ d'application de la formule révisée de 
Schwartz et propose une nouvelle formule certes plus complexe, mais facilement 
utilisable de nos jours grâce aux nouvelles technologies informatiques. Néanmoins, 
d'autres études sont nécessaires, par exemple afin d'évaluer la possibilité d'appliquer 
cette formule quadratique chez les enfants de moins de trois ans. En attendant, la 
formule quadratique, en tenant compte du contexte clinique, peut aider le pédiatre à 
prendre des décisions thérapeutiques et à suivre les enfants. 
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The most widely used formula for estimating glomerular 
filtration rate (eGFR) in children is the Schwartz formula. lt 
was revised in 2009 using iohexol clearances with measured 
GFR (mGFR) ranging between 15 and 75ml/minx1.73 m2• 
Here we assessed the accuracy of the Schwartz formula using 
the inulin clearance (iGFR) method to evaluate its accuracy 
for children with less renal impairment comparing 551 iGFRs 
of 392 children with their Schwartz eGFRs. Serum creatinine 
was measured using the compensated Jaffe method. ln order 
to find the best relationship between iGFR and eGFR, a linear 
quadratic regression model was fitted and a more accurate 
formula was derived. This quadratic formula was: 0.68x 
(Height (cm)/serum creatinine (mg/dl)) -- 0.0008x (height 
(cm)/serum creatinine (mg/dl))2 + 0.48x age (years) -- (21.53 
in males or 25.68 in females). This formula was validated 
using a split-half cross-validation technique and also 
externally validated with a new cohort of 127 children. 
Results show that the Schwartz formula is accurate until a 
height (Ht)/serum creatinine value of 251, corresponding to 
an iGFR of 103ml/minx1.73 m2, but significantly unreliable 
for higher values. For an accuracy of 20 percent, the 
quadratic formula was significantly better than the Schwartz 
formula for ail patients and for patients with a Ht/serum 
creatinine of 251 or greater. Thus, the new quadratic formula 
could replace the revised Schwartz formula, which is accurate 
for children with moderate renal failure but not for those 
with less renal impairment or hyperfiltration. 
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The exact determination of the glomerular filtration rate 
(GFR) is often critical to patients in clinical practice, for 
instance in the intensive care unit, after organ transplanta-
tion, or for drug dosage adjustment. Severa! methods for 
assessing truc GFR exist and require the administration of 
exogenous markers such as inulin, iohexol, 51 Cr-EDTA, or 
9901Tc-diethylenetriaminepentaacetic acid. Ail these markers 
are freely filtered by the glomerulus and are neither 
reabsorbed nor secreted by tubules. Measuring GFR with 
the above-mentioned techniques can be difficult to perform, 
invasive, time-consuming, and costly, and they are not 
available in ail health-care facilities. To avoid these draw-
backs, varions bedside formulas to estimate GFR were 
developed using serum creatinine (SCreat) as a marker of 
the renal function. 
In adults, the commonly used formulas are the well-
known Cockcroft Gault formula, 1 the Modification of Diet in 
Rena! Disease formula, 2 and the more recently developed 
Chronic Kidney Disease Epidemiology Collaboration 
formula. 3 It is recognized that these formulas are not 
applicable to the pediatric population. Severn] formulas 
were therefore developed for this population group.4-{i The 
most widely used formula is the Schwartz formula,7 
cleveloped in the l 970s and recently revised to take into 
account the new methods of SCreat measurements. 8 Since its 
publication, several studies have assessed the external validity 
of the revised Schwartz formula. Staples et 11/. 9 found a good 
agreement when applying this formula to children with no 
renal insufficiency. Similarly, Bacchetta et al. Hl concluded 
from their data set of children with moderate renal failure 
and normal GFR that the Schwartz bedside formula is 
accurate, However, Pottel et 111. 11 suggested adding an age-
dependent modification to the constant k for healthy 
children. 
The revisecl Schwartz formula 8 was derived from data 
obtained in children with measured GFR (mGFR) between 15 
and 75ml/minxl.73m2 (using iohexol clearance), and.thus 
its applicability to children with Jess renal insufficiency or 
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to children with normal renal fonction remains questionable 
at best. 
Because of these limitations to the widespread application 
of the Schwartz formula, the aim of the study was to provide 
additional data to assess the accuracy of the revised Schwartz 
formula by using another gold-standard method of mGFR 
determination, i.e., inulîn clearance (iGFR), in a cohort of 
children with renal failure, but also in children with normal 
renal function or even supra-normal GFR, i.e., hyperfiltration. 
RESULTS 
Demographics 
Original data set. Five hundred and fifty-one iGFRs 
performed between 2005 and 2010 in 392 children were 
evaluated. Demographîc characterîstics of the population are 
summarized in Table la. Mean values ± s.d. for age, body 
weight (BW), and Ht were 1 l.44 ± 3.93 years (range 2.9-
17.98), 40.62 ± 17.85 kg (range 13-113.2), and 144.8 ± 
21.43 cm (range 94.5-188.5), respectively. Twenty-three 
children presented with growth retardation for BW (5.8% 
of ail patients), 14 presented with growth retardation for 
Ht (3.5% of ail patients), and 34 presented with combined 
growth retardation for both BW and Ht (8.6% of all 
patients). Rena! disorders are summarized in Table 2. 
Complementary data set. In a prospective manner, an 
external validation data set was conducted. One hundred and 
twenty-seven iGFRs were analyzed between 2010 and 2012 in 
127 children. Children included in the original cohort were 
excluded from this complementary cohort. Demographic 
characteristics of this complementary data set are as follows: 
Mean values± s.d. for age, BW, and Ht were 12.42 ± 4.1 years 
(range 3-18.0), 39.5 ± 16 kg (range 15-95), and 149.6 ± 
21.88 cm (range 93.8-194.5), respectively. For the whole 
cohort, mean values± s.d. for iGFRs and eGFRs using the 
new quadratic formula and the revised Schwartz formula 
were 85.66 ± 21.67, 89.44 ± 20.88, and 90 ± 24.78, respectively 
(Table lb). 
Correlation between iGFRs and the revised Schwartz formula 
The revised Schwartz formula de pends on the ratio of the two 
following variables: the Ht and SCreat. The distribution of 
iGFRs corresponding to this variable ratio (Ht/SCreat) is 
presented in Figure la and b. When applying the revised 
Schwartz formula to our original data set, we observed a 
linear correlation between eGFRs and iGFRs and a symmetric 
distribution of iGFRs along this line until a point from which 
eGFR systematically overestimates true iGFR (Figure la). 
To better define the points of change where the revised 
Schwartz formula overestimates iGFR, we applied the circular 
binary segmentation method for all the bias values of the 
revised Schwartz formula. This method demonstrates 
the presence of a one point of change equals to 251 of the 
variable ratio of Ht/SCreat corresponding to an iGFR of 
103ml/minx1.73 m 2 (Figure 2a). 
In fact, the best relation between the iGFR and the variable 
ratio of Ht/SCreat is quadratic (Figure 1 b). For these reasons, 
we derived a new quadratic equation by fitting a robust linear 
quadratic mode!, applicable to al! GFR values and taking into 
account the age and the sex of the patient. Of note, and 
contrary to the revised Schwartz formula, when applying the 
circular binary segmentation method to al! bias values of our 
new quadratic formula, no change points were detected 
Table 1 b 1 Mean± s.d. for iGFRs and eGFRs using the new 
quadratic and the revised Schwartz formulas in the 
validation data set 
s.d. of 
Mean of s.d. of Mean of eGFR 
Mean s.d. eGFR using eGFR using eGFR using using 
Ht/ of of quadratic quadratic Schwartz Schwartz 
SCreat iGFR iGFR formula formula formula formula 
<251 81 22 83.26 20.24 80.72 19.51 
?251 100.10 11.88 108.57 5.92 118.74 15.91 
Total 85.66 21.67 89.44 20.88 90 24.78 
Abbrevlations: eGFR, estimated glomerular filtration rate; iGFR, lnulin clearance; Ht/ 
SCreat, height/serurn creatinine. 
iGFRs and eGFRs are expressed in rnl/lnin x 1.73 rn2• 
Table 2 I Characteristics and classification of patients' renal 
disorders 
CKD CKD CKD CKD stages 4 
Etiologies stage 1 stage 2 stage 3 and 5 
Obstructive or reflux uro- 150 86 11 2 
pathy 
Congenital and acquired 57 38 4 0 
single kidney 
Polycystic kidney disease 9 6 4 0 
Glomerulopathies 19 8 4 2 
Hemo\ytic and uremic 8 1 4 
syndrome 
Metabolic disease 2 4 6 2 
Post-chemotherapy 6 6 11 0 
Post-pyelonephritis 12 6 0 0 
Other 39 24 15 4 
Total: 551 295 186 56 14 
Abbreviation: CKD, chronic kidney disease. 
CKD stages 1. 2, 3, 4, and 5 denote glornerular filtration rate (GFR) ;io 90, 60-89, 
30-59, 15-29, and< 15 ml/rnin x 1.73 m2, respectively. 
Table 1a 1 Populations' demographic characteristics for the original data set 
Mean of s.d. Mean of 
Ht/ Number Percentage age of Minimum of Maximum of height s.d. of Mean of s.d. of Mean of crea- s.d. of 
SCreat n of female of female (years) age age (years) age (years) (cm) height weight weight tinine (mg/dl) creatinine 
<251 414 185 44.69 12.17 3.77 2.9 17.98 148.1 20.7 43.3 18 0.85 0.42 
?251 137 59 43.07 9.24 3.59 3.34 17.26 134.9 20.6 32.6 14.9 0.48 0.09 
Total 551 244 44.28 11.44 3.93 2.9 17.98 144.8 21.43 40.62 17.85 0.76 0.40 
Abbreviation: Ht/SCreat, height/serurn creatinine. 
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tee h 1 notes 
.(Fig~re 2b), which means that the new quadratic formula is 
applicable to all GFR values. 
The new quadratic formulas c c 1 
· ior iema e and male 
mdivid uals are as follows: 
Females: 
0.68 X (Height/serurn creatinine) - 0.0008 
x (height/serum creatinine)2 + 0.48 xage - 21.53 
Males: 
0.68 X (Height/serum creatinine) - 0.0008 
x (height/senun creatinine )2 + 0.48 xage - 25,68 
g:t in cm, SCreat in mg/dl, age in years). 
Females: 
60 X (Height/serum creatinine) - 6.25 
x (height/serum creatinine )2 + 0.48 x age - 21.53 
Males: 
60 X (H eight/serum creatinine) - 6.25 
x(height/serum creatinine)2 + 0.48xage - 25.68 
(Ht in cm; SCreat in µ1110]/]; age in years), 
New quadratic formula: checking for overfitting 
To check for overfitting, first we calculated a sh .' k 
coefficient 'y' h · l ' i 111 age 
. ' w ic 1 measures the flattening of the plot of 
pr~~~~~~d (eGFR). versus observed (iGFR) values away from 
~5 : We obtamed a Y value of 0.0055281 ( < 1 %)· this 
md1cates that :- 1 % of the rnodel fit is noise. In additio;1, we 
perforrned an mternal and an external validation of th. 
formula. is new 
Model validations 
. '~.tern~/ m_odel valid~tion (original data set). A split-half 
cro~s-vahdation techmque was performed to as 
:l l fi 1 , sess our 
moc e it/acc~r~cy. 4 We divided our data set into two 
halves: the trammg set, on which the mode] was fitted . :l 
tl t f ' ,ml 1~ es mg set, ?n which the mode] was evaluated. The 
esti~ated coefficients on the training set are then used to 
pre~lCt outc~me scores of the training set, as well as of the 
testmg set. fhe residual squared errors (RSEs) were th 
calculated fo~ the training set and for the testing set using t~: 
ne': quadrahc formula and the revised Schwartz formula 
This allows the comparison of the RSE between the t. . . . 
s ·t d th · 1a111111g f. e. a~ e testi~g set for the new quadratic formula and also 
or t., e. ~~mpanson of RSE between the new quadratic and 
the revised Schwartz formulas on the same data set (test' 
set) .. In addition, the correlation coefficient betw;:i~ 
predtcte.d and observed values was calculated for the new 
qua.drattc and for the revised Schwartz formulas on the ' 
testmg set. sarne 
3 
The split-half cross-validation was done with 500 boot-
strap replications, and the results are summarized in Table 3. 
The calculated mean error (mean RSE) of the quadratic 
formula on the testing set is slightly larger than the mean RSE 
calculated on the training set (mean difference = 156-149.7 
= + 6.3). However, for the revised Schwartz formula, the 
mean RSE is very large (mean difference = 197.5-149.7 = 
+ 47.8). The mean correlation coefficient between the 
predicted and the observed values on the testing set is 0.85 
and 0.82 for the quadratic formula and the revised Schwartz 
formula, respectively. 
When the new quadratic formula and the revised Schwartz 
formulas were applied to the whole population, we found a 
mean RSE of 151.5 and 196.4, with a mean correlation 
coefficient of 0.86 and 0.83, respectively. 
External mode/ validation (complementary data set). The 
estimated coefficients for the new quadratic formula from 
the original cohort were used to predict scores on the 
complementary cohort. The RSE of the new quadratic 
formula on the complementary cohort is 157.2 (compared 
with 156 in the original cohort), and the correlation between 
the predicted and observed values is 0.84. These results show 
an excellent performance of the new quadratic formula. In 
addition, the RSE of the revised Schwartz formula on this 
complementary data set is 267 .17, which confirms the low 
performance of this formula for eGFR. A scattered plot 
depicting the relationships between iGFRs and eGFRs using 
the new quadratic formula (Figure 3a) and the revised 
Schwartz formula (Figure 3b) shows an overall better 
performance of the quadratic formula, whereas the Schwartz 
formula overestimates GFR, and this again at high iGFR 
values. 
Comparison of the revised Schwartz formula and the 
quadratic formula 
Table 4 summarizes the results and shows the different 
performances of the revised Schwartz formula and the new 
quadratic formula. Considering ail patients, there is no 
significant difference between the two formulas (P = 0.9) for 
an accuracy within 10%. However, when considering an 
accuracy within 20%, the new quadratic formula shows 
Table 3 I RSEs in the training set and testing set, correlation 
coefficient between iGFRs and eGFRs using the new 
quadratic and the revised Schwartz formulas 
Minimum 
1 st quartile 
Median 
Mean 
3rd quartile 
Maximum 
RSE; correlation 
coefficient using 
the quadratic 
formula on the 
Training set RSE testing set 
123.9 129.1; 0.796 
143.9 150.3; 0.843 
149.4 155.9; 0.853 
149.7 156.0; 0.851 
155.5 162.1; 0.861 
175.2 189.2; 0.884 
Abbreviation: RSE, resldual squared errer. 
4 
RSE; correlation 
coefficient using 
the revised Schwartz 
formula on the 
testing set 
161.5; 0.766 
188.8; 0.814 
197 .6; 0.825 
197.5; 0.824 
205.5; 0.837 
236.7; 0.872 
significantly better results (P = 0.04) than the revised 
Schwartz formula. The higher precision and accuracy of the 
new quadratic formula was especially more appropriate for 
patients with Ht/SCreat over 251, corresponding to a 
mGFR;, 103 ml/min x 1.73 m 2 (P-values of 0.02 and 0.001 
for an accuracy of 10% and 20%, respectively). 
We also divided our original data set into three groups for 
bias analysis: group 1, iGFR'(75ml/minxl.73m2 (11=116); 
group 2, iGFR between 75 and 103ml/minx1.73 m2 
(n = 298); and group 3, iGFR;, 103ml/minx1.73 m 2 
(n = 137). With the revised Schwartz formula, there is a 
significant difference in bias between groups 1 and 3 
(P<0.00) (mean values ± s.d. of bias for groups 1 and 3 
are - 2.38 ± 12.96 and 10.72 ± 13.81, respectively). There is 
also a significant difference in bias between the groups 2 and 
3 (P<0.00) (mean values± s.d. ofbias for groups 2 and 3 are 
- 2.6 ± 12.25 and 10.72 ± 13.81, respectively), but there is no 
significant difference between groups l and 2 (P = 0.5) (mean 
values± s.d. of bias for groups 1 and 2 are - 2.38 ± 12.96 and 
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Figure 3 I Relationships between inulin clearances (iGFRs) and 
estimated glomerular filtration rates (eGFRs) in the 
complementary data set. Using (a) the new quadratic formula and 
(b) the revised Schwartz formula. 
Table 4 I Performances of the revised Schwartz formula and 
the new quadratic formula 
Ali patients 
Schwartz formula 
Quadratic formula 
P-value 
Patients with heightlcrea-
tinine <251 
Schwartz formula 
Quadratic formula 
P-value 
Patients with heightlcrea-
tinine ~251 
Schwartz formula 
Quadratic formula 
P-value 
n 
551 
551 
414 
414 
137 
137 
Accuracy within 
10% of iGFR 
47%; 
50%; 
0.9 
46%; 
47%; 
0.4 
48%; 
60%; 
0.02 
Accuracy within 
20% of iGFR 
79%; 
83%; 
0.04 
80%; 
81%; 
0.2 
75%; 
89%; 
0.001 
Height ln cm; IGFR; inulin clearance; n, patient number; serum creatlnine in mg/dl. 
Slgnificance was defined as P <a.os. 
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- 2.6 ± 12.25, respectively). With the new quadratic formula, 
there is no significant difference in bias between ail groups 
(mean values± s.d. of bias for groups 1, 2, and 3 are 
0.44 ± 11.97, - 1.13 ± 11.95, and 1.82 ± 13.23, respectively). 
Furthermore, in contrast to the new quadratic formula, 
the revised Schwartz formula was not adjusted for age and 
sex. Figure 4a and b compare these formulas at two extreme 
ages ( 4 and 17 years), and demonstrate the effect of age and 
sex on the eGFR. They also show the range of reliability using 
the Schwartz formula in these two extreme ages. 
DISCUSSION 
SCreat is, and remains, the most commonly used endogenous 
marker of renal fonction. It is easily measured and therefore 
available in most laboratories worldwide. To evaluate GFR, 
several formulas were developed, extrapolating from the 
SCreat values. The most commonly used formula in children 
is the Schwartz formula, revised in 2009.8 There are several 
limitations to the widespread use of the revised Schwartz 
formula, mainly its precision and accuracy in children with a 
GFR above 75 or below 15ml/minx1.73 m 2 • Furthermore, 
the revised formula is not adjusted for age or sex, in contrast 
to the previous Schwartz formula. Our data set provides a 
forther validation of the revised Schwartz formula, as we 
found a good agreement for children with a GFR between 15 
and 103ml/minx1.73 m 2, confirming what other studies 
have also found .. However, we observed that the revised 
Schwartz formula performs poorly at Ht/SCreat values 
exceeding 251, corresponding to higher GFR levels. Above 
that value, the Schwartz formula significantly overestimatcs 
mGFRs. Our results are in line with previously published 
reports. Bacchetta et a 1. 10 and Po ttel et a 1. 11 already showed 
that for a GFR above 90ml/minx1.73 m 2 the new Schwartz 
formula !oses its accuracy. Staples et al. 9 and Berg et al. 15 both 
observed an underestimation in GFR above 90 and 60 ml/ 
min x 1.73 m 2, respectively, but authors questioned whether 
their findings were related to the small number of patients 
studied. In addition, we found a significant effect of age and 
sex on the prediction of GFR. Therefore, and in contrast to 
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Figure 4 I Relationships between estimated glomerular filtration 
rates (eGFRs) and the variable ratios of height over serum 
creatinine (Ht/SCreat) using the revised Schwartz formula (green 
line) and the new quadratic formula (blue curve for boys and 
pink curve for girls), (a) Children aged 4 years. (b) Children aged 
17 years. eGFR is expressed in ml/min x 1.73 m 2, height (Ht) in cm, 
SCreat in mg/dl. 
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the revised Schwartz formula, the new quadratic formula has 
been adjusted for age and sex. 
Our study is the first one to describe a precise cutoff for 
the validity of the revised Schwartz formula, and allows 
deriving a new generalized formula, applicable to all GFR 
values. 
The new quadratic formula, validated against iGFRs in 
two independent cohorts, assessed GFR equally well or more 
precisely than the revised Schwartz formula across a wide 
variety of clinical conditions. It is the first one to take into 
account children with normal or supra-normal GFR. The bias 
and accuracy improvements for higher estimated GFRs in 
which Ht/SCreat are above 251, corresponding to iGFRs 
above 103ml/minx1.73 m 2, have important implications for 
public health and clinical practice. This is particularly 
important in conditions such as diabetes mellitus, where 
hyperfiltration has an important role in the progressive 
deterioration of the renal fonction and puts the children at 
risk for secondary glomerulosclerosis if left untreated. 
Although more complex than the revised Schwartz 
formula, the new quadratic formula can readily be im-
plemented into daily clinical work, at the bedside, with the 
use of persona! computers. We have developed a JavaScript 
application that can be downloaded from our website using 
the following link: http://www.chuv.ch/quadraticformula. We 
also developed a calculator for applying this formula, which 
can also be found on this website. 
Ali creatinine-based formulas for calculating eGFR depend 
strongly on the accuracy of SCreat measurement. The most 
important problem is that the methocls used to assay 
creatinine in the blood differ widely in their susceptibility 
to nonspecific chromogens, which causes the creatinine value 
to be overestimated. The National Kidney Disease Education 
Program in the United States has attempted to solve this 
problem by trying to get all laboratories to calibrate their 
measurements of creatinine against a 'gold standard', which is 
isotope dilution mass spectrometry. In our study, ail plasma 
creatinine assays were performed in one laboratory with one 
method ( compensated Jaffe technique, which is standardized 
against the isotope dilution mass spectrometry method). 
However, we cannot rule out that some of the differences in 
performance between the new quadratic formula and the 
revised Schwartz formula could be secondary to the different 
creatinine measurement methods used (the compensated 
Jaffe method vs. the enzymatic method). 
We are aware of a few limitations in our study. Although 
some authors prefer cystatin C-based formulas or combined 
cystatin C and creatinine formulas 16 and challenge the use of 
creatinine formula, these formulas have not proven to be 
superior to creatinine-based formulas. 17 We could not 
compare formulas using cystatin C, as cystatin C was not 
measured. Furthermore, our new formula does not overcome 
limitations of SCreat in some patients, which depend on 
muscle mass levels. It is important to note that we did not 
have muscle mass evaluations in our population, but no 
infant was diagnosed with myopathy. Moreover, we did not 
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Figure 5 I Bland-Altman agreement between enzymatic and 
colorimetric serum creatinine (SCreat) measurements. SCreat is 
expressed in µmol/1. 
include children below the age of 2 years in our study; 
therefore, we cannot make any conclusions for that age 
category. Severa! studies suggest that GFR estimation in 
infants is different from that of older children. 18• 19 In the 
same vein, the influence of Tanner stages was not assessed, as 
Tanner stages were not recorded. Further studies will be 
needed to determine whether pubertal status impacts further 
on the new quadratic formula. Finally, 159 children were 
studied twice; however, this group was included several years 
a part, with a minimum time frame of 2 years between the two 
exams. Given the major demographic differences between the 
two exams (age, Ht, and renal disease progressions), this 
should not weaken the conclusions of our study. 
ln conclusion, using the data of more than 500 clearances 
with values ranging between 17 and 150ml/minx1.73 m2 , in 
children with various renal diseases, we have been able to 
generate a more precise and generalizable quadratic formula, 
applicable to ail GFR values and also to children with faîlure 
to thrive. Although less exact than iGFR, this new quadratic 
formula is a good alternative for GFR estimation in children. 
MATERIALS AND METHODS 
Population 
Demographic characteristics and patients' renal disorders are 
presented in Tables 1 and 2. 
Details of methods and population section are available on line in a 
supplementary file at wwvv.nature.com/ki 
Analytical analysis 
SCreat was measured using the kinetic colorimetric compensated Jaffe 
method, which is closely aligned with the enzymatic assay (Figure 5) 
and standardized against the reference isotope dilution mass spectro-
metry method. iGFR was measured using the anthrone test. eGFR was 
calculated according ta the revised Schwartz formula as follows: eGFR 
(ml/minx 1.731112) = 0.413xHt (cm)/SCreat (mg/dl). 
Statistical analysis 
To overcome the problem of overestimation of eGFR calculated by 
the Schwartz formula, a robust linear quadratic regression mode! 
was fitted and a more accurate quadratic formula was derived. The 
cutoff at which the eGFR using the revised Schwartz formula tends 
to overestimate iGFR was determined using the circular binary 
6 
A Gao et al.: Quadratic formula for GFR estimation in children 
segmentation method.20 To quantify the quadratic mode! 
overfitting, we calculated the shrinkage coefficient y. 12•13 An 
internai validation method using the split-half cross-validation 
technique was performed with 500 bootstrap replications to assess 
the fit and/or predictive accuracy of the new elaborated formula and 
to evaluate the Schwartz formula. Our sample was randomly split 
into two independent groups: the training set, on which our mode! 
was fitted, and the testing set, on which our mode! and the Schwartz 
formulas were evaluated. An external validation of the quadratic 
formula with a complementary data set was also conducted. The 
RSE and the correlation coefficient for the quadratic and the 
Schwartz formulas were calculated in the internai and the external 
validation data set. The quadratic formula was also compared with 
the Schwartz formula in tenns of bias, precision, and accuracy. 
Statistical significance was defined as P < 0.05. 
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